Stroke and Cerebrovascular Disease

References

Adibhatla RM, Hatcher JF, et al. CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke. Brain Research. 2005;(1058:193–7.

Ahsan SK. Magnesium in health and disease. J Pak Med Assoc. 1998;(48):246–50.

Ansari MA, Ahmad AS, et al. Selenium protects cerebral ischemia in rat brain mitochondria. Biol Trace Elem Res. 2004 Oct;101(1):73–86.

Appel LK, Moore TJ, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;(336):1117-24.

Ascherio A, Willitt WC. Health effects of trans-fatty acids. Am J Clin Nutr. 1997 Oct;66(4 Suppl):1006S–1010S. Review.

Barbagallo M, Dominguez LJ, et al. Effects of vitamin E and glutathione on glucose metabolism. Role of magnesium. Hypertension. 1999 Oct;34(4 Pt 2):1002–6.

Barrett S, Shils ME. Alternative nutrition therapies. In: Modern Nutrition in Health and Disease. 10th ed. Lippincott Williams & Wilkins; 2006:1768.

Bazzano LA, He J, et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke. 2002 May;33(5):1188–9.

Boger RH, Eyal SR. L-arginine improves vascular function by overcoming the deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med Rev. 2005 March;10(1):14–23.

Bostom AG, Shemin D, et al. Lack of effect of oral N-acetylcystein on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients. Atherosclerosis. 1996 Feb;120(1–2):241–4.

Boucher BJ. Inadequate vitamin D status: Does it contribute to the disorders comprising syndrome ‘X’? Br J Nutr. 1998 Apr;79(4):315–27. Review.

Broadhurst CL. Balanced intakes of natural triglycerides for optimum nutrition: An evolutionary and phytochemical perspective. Med Hypotheses. 1997 Sep;49(3):247–61.

Bueno R, Alvarez de Sotomayor M, et al. L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: Different participation of NO and COX-products. Life Sci. 2005 Sep 9;77(17):2082–97.

Burger KM, Horowitz DR. Thrombolytic treatment of acute cerebral infarction. CNS Spectr. 2005 Jul;10(7):539–49.

Calo LA, Pagnin E, et al. Antioxidant effect of L-carnitine and its short chain esters: Relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol. 2006 Feb 8;107(1):54–60.

Chang HS, Yamato O, et al. Modulatory influence of sodium 2-propenyl thiosulfate from garlic on cyclooxygenase activity in canine platelets: Possible mechanism for the anti-aggregatory effect. Prostaglandins Leukot Essent Fatty Acids. 2005 May;72(5):351–5.

Chionglo BM, Shils ME, et al. Arginine and nitric oxide. In: Modern Nutrition in Health and Disease. 10th ed. Lippincott Williams & Wilkins; 2006:571–81.

Clark WM, Warach SJ, et al. A randomized dose-response trial of citicoline (CDP-choline) in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology. 1997 Sep;49(3):671–8.

Clarke CRA. Neurological disease. In: Kumar P, Clark M, eds. Clinical Medicine: A Textbook for Medical Students and Doctors. WB Saunders, Harcourt Brace and Co.; 1998:1046–55.

Dakshinamurti K, Lal KJ. Vitamins and hypertension. In: Simopoulos AP, ed. Nutrients in the Control of Metabolic Diseases. World Rev Nutr Diet. 1996(69):40–73.

Danesh J, Lewington S, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA. 2005 Oct 12;294(14):1799–809. Erratum in: JAMA. 2005 Dec 14;294(22):2848.

Davalos A. Thrombolysis in acute ischemic stroke: Successes, failures, and new hopes. Cerebrovasc Dis. 2005;20 Suppl 2:135–9.

DeBusk RM. Dietary supplements and cardiovascular disease. Curr Atheroscler Rep. 2000 Nov;2(6):508–14. Review.

Dezsi L, Kis-Varga I, et al. [Neuroprotective effects of vinpocetine in vivo and in vitro: Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke]. Acta Pharm Hung. 2002;72(2):84–91.

Di Napoli N, et al. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001;32:133–8.

Di Napoli N, Papa F, et al. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke. 2001;32:917–24.

Digiesi V, Cantini F, et al. Coenzyme Q10 in essential hypertension. Mol Aspects Med. 1994;15 Suppl:s257–s263.

Digiesi V, Cantini F, et al. Effect of coenzyme Q10 on essential hypertension. Curr Ther Res. 1990(47):841–5.

Duffy SJ, Gokee N, et al. Treatment of hypertension with ascorbic acid. Lancet. 1999 Dec 11;354(9195):2048–9.

Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta. 1995 May 24;1271(1):195–204. Review.

Enstrom JE, Kanim LE, et al. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992 May;3(3):194–202.

Fotherby MD, Williams JC, et al. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens. 2000 Apr;18(4):411–5.

Gale CR, Martyn CN, et al. Vitamin C and risk of death from stroke and coronary heart disease in a cohort of elderly people. BMJ. 1995 Jun 17;310(6994):1563–6.

Galley HF, Thornton J, et al. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci. 1997 Apr;92(4):361–5.

Gariballa SE. Nutritional factors in stroke. Br J Nutr. 2000 Jul;84(1):5–17.

Gavish D, Breslow JL. Lipoprotein(a) reduction by N-acetylcysteine. Lancet. 1991 Jan 26;337(8735):203–4.

Gillman MW, Cupples A, et al. Inverse association of dietary fats with development of ischemic stroke in men. JAMA. 1997(278):2145–50.

Goldstein LB, Adams R, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2001 Jan 2;103(1):163–82.

Gorelick PB, Sacco RL, et al. Prevention of a first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999 Mar 24–31;281(12):1112–20. Review.

Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke. 2002 Mar;33(3):862–75. Review.

Grau AJ, Brandt T, et al. Association of cervical artery dissection with recent infection. Arch Neurol. 1999 Jul;56(7):851–6.

Grau AJ, Buggle F, et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: Clinical and biochemical studies. Neurology. 1998 Jan;50(1):196–203.

Grau AJ, Buggle F, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke. 1995 Mar;26(3):373–9.

Hadjiev D. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine. Ideggyogy Sz. 2003 May 20;56(5–6):166–72. Review.

Hajjar IM, Grim CE, et al. Impact of diet on blood pressure and age-related changes in blood pressure in the US population. Arch Intern Med. 2001 Feb 26;161(4):589–93.

Hak AE, Ma J, et al. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke. 2004 Jul;35(7):1584–8.

He K, Merchant A, et al. Folate, vitamin B6 and B12 intakes in relation to risk of stroke among men. Stroke. 2004 Jan;35(1):169–74.

He K, Rimm EB, et al. Fish consumption and risk of stroke in men. JAMA. 2002 Dec 25;288(24):3130–6.

Hirvonen T, Virtamo J, et al. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke. 2000 Oct;31(10):2301–6.

Holick MF, Shils ME Sr. Ed.Vitamin D1. Modern Nutrition in Health and Disease. 10th ed. Lippincott Williams & Wilkins 2006:376–95.

Hollander M, Hak AE, et al. Comparison between measures of atherosclerosis and risk of stroke: The Rotterdam Study. Stroke. 2003 Oct;34(10);2367–72.

Hong JT, Ryu SR, et al. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res. 2001 Jan 5;888(1):11–8.

Horowitz JD. Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infarction. Am J Med. 1991 Sep 30;91(3C):113S–117S. Review.

Hultberg B, Andersson A, et al. The effects of homocysteine and copper ions on the concentration and redox status of thiols in cell line cultures. Clin Chim Acta. 1997 Jun 27;262(1–2):39–51.

Jeerakathil TJ, Wolf PA. Prevention of strokes. Curr Atheroscler Rep. 2001 Jul;3(4):321–7.

Jiang B, Haverty M, et al. N-acetylcysteine enhances interleukin-1B-induced nitric oxide synthase expression. Hypertension. 1999 Oct;34(4 Pt 1):574–9.

Johnsen SP. Intake of fruit and vegetables and risk of stroke: An overview. Curr Opin Clin Nutr Metab Care. 2004 Nov;7(6):665–70.

Kaposzta Z, Baskerville PA, et al. L-arginine and S-nitrosoglutathione reduce embolization in humans. Circulation. 2001 May 15;103(19):2371–5.

Kelly PJ, et al. Mild-to-moderate hyperhomocyst(e)inemia and risk of stroke. Abstracts of the International Stroke Conference. 2000 32: 366.

Kelly PJ, Shih VE, et al. Low vitamin B6 but not homocysteine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke. 2003 Jun;34(6):e51–4.

Kirchhoff K, Schramm P, et al. [The value of multi-slice computed tomography for early diagnosis of focal cerebral ischemia]. Rofo. 2002 Sep;174(9):1089–95. Review.

Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil: A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med. 1989 Apr 20;320(16):1037–43.

Koga Y, Akita Y, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology. 2005 Feb 22;64(4):710–2.

Kontush A. Plasma ubiquinol is decreased in patients with hyperlipidemia. Atherosclerosis. 1997 Feb 28;129(1):119–26.

Kris-Etherton PM, Harris WS, et al. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular diseases. Circulation. 2002 Nov 19;106(21):2747–57.

Kurl S, Tuomainen TP, et al. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke. 2002 Jun;33(6):1568–73.

Langsjoen PH, Langsjoen AM. Overview of the use of Co Q10 in cardiovascular disease. Biofactors. 1999;9(2–4):273–84. Review.

Lee SY, Kim CY, et al. Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain Res Bull. 2003 Aug 30;61(4):399–406.

Leppala JM, Virtamo J, et al. Vitamin E and beta carotene supplementation in high risk for stroke: A subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Arch Neurol. 2000 Oct;57(10):503–9.

Lind L, Hanni A, et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995 Sep;8(9):894–901.

Lu Q, Bjorkhem I, et al. N-acetylcysteine improves microcirculatory flow during smoking: New effects of an old drug with possible benefits for smokers. Clin Cardiol. 2001 Jul;24(7):511–5.

Ma J, Hennekens CH, et al. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians’ Health Study. J Am Coll Cardiol. 1999 Apr;33(5):1347–52.

Marniemi J, Alanen E, et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):188–97.

Meier CR, Derby LE, et al. Antiobiotics and risk of subsequent first-time acute myocardial infarction. JAMA. 1999 Feb 3;281(5):427–31.

Meister A, Anderson ME, et al. Intracellular cysteine and glutathione delivery systems. J Am Coll Nutr. 1986;5(2):137–51.

Moat SJ, Lang D, et al. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem. 2004 Feb;15(2):64–79. Review.

Morisco C, Trimarco B, et al. Effect of coenzyme Q10 therapy in patients with congestive heart failure: A long-term multicenter randomized trial. Clin Invest. 1993;71(8 Suppl):S134–S136.

Morrison JA, Jacobsen DW, Sprecher DL, Robinson K, Khoury P, Daniels SR. Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation. 1999 Nov 30;100(22):2244-7.

Mosley TH Jr, Knopman DS, et al. Cerebral MRI findings and cognitive functioning: The Atherosclerosis Risk in Communities study. Neurology. 2005 Jun 28;64(12):2056–62.

National Institute of Neurological Disorders and Stroke (NINDS). National Institutes of Health. U.S. Dept. of Health and Human Services. Pub. No. 02–3440b. Available at: www.ninds.nih.gov. Accessed August 2005.

National Stroke Association. Available at: http://info.stroke.org/site/PageServer?pagename=TYPE. Accessed January 2006.

Nieto FJ, Folsom AR, et al. Chlamydia pneumoniae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999 Jul 15;150(2):149–56.

Postiglione A, Cicerano U, et al. Cerebral blood flow in patients with chronic cerebrovascular disease: Effect of acetyl L-carnitine. Int J Clin Pharmacol Res. 1990;10(1–2):129–32.

Postiglione A, Soricelli A, et al. Effect of acute administration of L-acetyl carnitine on cerebral blood flow in patients with chronic cerebral infarct. Pharmacol Res. 1991 Apr;23(3):241–6.

Prasad A, Andrews NP, et al. Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability. J Am Coll Cardiol. 1999 Aug;34(2):507–14.

Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol. 1998 Jun;51(6):443–60. Review.

Rebouche CJ, Shils ME Sr. Ed. Carnitine. Modern Nutrition in Health and Disease. 10th ed. Lippincott Williams & Wilkins 2006:537–44.

Ridker PM, Cushman M. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr 3;336(14):973–9. Erratum in: N Engl J Med. 1997 Jul 31;337(5):356.

Ridker PM, Buring JE, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998 Aug 25;98(8):731–3.

Sacks FM, Svetkey LP, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Eng J Med. 2001 Jan 4;344(1):3–10.

Sainani GS, Sainani R. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease. Assoc Physicians India. 2002 May;50 Suppl:16–23. Review.

Sauvaget C, Nagano J, et al. Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke. 2003 Oct;34(10):2355–60.

Schwammenthal Y, Tanne D. Homocysteine, B-vitamin supplementation, and stroke prevention: From observational to interventional trials. Lancet Neurol. 2004 Aug;3(8):493–5.

Schweizer U, Brauer AU, et al. Selenium and brain function: A poorly recognized liaison. Brain Res Brain Res Rev. 2004 Jul;45(3):164–78. Review.

Simon JA. Vitamin C and cardiovascular disease: A review. J Am Coll Nutr. 1992 Apr;11(2):107–25. Review.

Spence JD, Bang H, et al. Vitamin Intervention For Stroke Prevention trial: An efficacy analysis. Stroke. 2005 Nov;36(11):2404–9.

Stanford Stroke Center. Available at: http://strokecenter.stanford.edu/guide/what_is_stroke.html. Accessed January 2006.

Suslina ZA, Fedorova TN, et al. Antioxidant activity of mildronate and L-carnitine in the treatment of patients with cerebrovascular diseases. Eksp Klin Farmakol. 2003 May-Jun;66(3):32–5.

Suter PM. The effects of potassium, magnesium, calcium, and fiber on risk of stroke. Nutr Rev. 1999 Mar;57(3):84–8.

Suzuki M, Tabuchi M, et al. Protective effects of green tea catechins on cerebral ischemic damage. Med Sci Monit. 2004 Jun;10(6):BR166–BR174.

Szapary L, Horvath B, et al. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease]. Orv Hetil. 2003 May 18;144(20):973–8.

Szilagyi G, Nagy Z, et al. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: A PET study. J Neurol Sci. 2005 Mar 15;229–30:275–84.

Tavani A, Negri E, et al. Margarine intake and risk of nonfatal acute myocardial infarction on Italian women. Eur J Clin Nutr. 1997 Jan;51(1):30–2.

Tazaki Y, Fumihiko S, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke. 1988;19(2):211–6.

Thomas JA, Shils ME Sr. Ed. Oxidant defense in oxidative and nitrosative stress. Modern Nutrition in Health and Disease. 10th ed. Lippincott Williams & Wilkins; 2006:685–694.

Toivanen JL. Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro. Prostaglandins Leukot Med. 1987 Mar;26(3):265–80.

Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Exp Physiol. 2005 Jul;90(4):449–55. Review.

Ullegaddi R, Powers HJ, et al. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clin Sci. 2004 Nov;107(5):477–84.

Ullegaddi R, Powers HJ, et al. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr. 2005 Dec;59(12):1367–73.

Vas A, Gulyas B, et al. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: A summary of evidences. J Neurol Sci. 2002 Nov 15;203–204:259–62. Review.

Vasdev S, Longerish L, et al. Role of aldehydes in hypertension. In: Sharma BK, Takeda N, et al, eds. Adaptation Biology and Medicine, vol. 1. New Delhi, India: Narosa Publishing House; 1997:326–39.

Vasdev S, Mian T, et al. Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induced hypertensive rats. Nutr Metab Cardiovasc Dis. 1996(6):130–40.

Voko Z, Hollander M, et al. Dietary antioxidants and the risk of ischemic stroke: The Rotterdam Study. Neurology. 2003 Nov 11;61(9):1273–5.

Wald DS, Law M, et al. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ. 2002 Nov 23;325(7374):1202.

Warach S, Pettigrew LC, et al. Effect of citicoline (CDP-choline) on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol. 2000 Nov;48(5):713–22.

Wiklund O, Fager G, et al. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. Atherosclerosis. 1996 Jan 5;119(1):99–106.

Willmot M, Gray L, et al. A systematic review of nitric oxide donors and L-arginine in experimental stroke: Effects on infarct size and cerebral blood flow. Nitric Oxide. 2005 May;12(3):141–9. Review.

Winkelstein JA, Childs B. Why do some individuals have more infections than others? JAMA. 2001 Mar 14;285(10):1348–9.

Wu T, Trevisan M, et al. Periodontal disease and risk of cerebrovascular disease: The First National Health and Nutrition Examination Survey and its follow-up study. Arch Intern Med. 2000 Oct 9;160(18):2749–55.

Yochum LA, Folsom AR, et al. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 2000 Aug;72(2):476–83.

Yokoyama T, Date C, et al. Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community. The Shibata study. Stroke. 2000 Oct;31(10):2287–94.

Zeisel SH, Niculescu MD, et al. Choline and phosphatidylcholine. In: Modern Nutrition in Health and Disease. Lippincott Williams & Wilkins: 2006;525–36.